ArticleBritish journal of cancer2016

First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanoma.

C Le Tourneau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.